Lesion-tailored, Fundus-controlled Perimetry in Geographic Atrophy (GA).
Part of paid clinical trials in Salt Lake City, Utah.
- Sponsor
- University of Utah
- Study ID
- NCT07582042
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Geographic Atrophy From Age-related Macular Degeneration
Eligibility Criteria
- Sex
- ALL
- Age
- 65 Years - 90 Years
- Healthy Volunteers
- Not accepted
Study Details
The goal of this observational study is to evaluate changes in retinal sensitivity over time in patients with geographic atrophy due to age related macular degeneration who are receiving pegcetacoplan as part of routine clinical care. The study aims to determine whether lesion tailored fundus-controlled perimetry can reliably measure functional changes near areas of atrophy and whether this testing can be implemented in everyday clinic care over 24 months. Participants will undergo repeated vision testing, standard eye imaging, and visual function questionnaires while continuing their prescribed treatment.
Key Dates
- Start date
- May 15, 2026
- Status verified
- May 2026
- Primary completion
- May 1, 2029
- Completion
- Aug 1, 2029
Study Design
- Enrollment
- 50 participants (estimated)
Primary Outcome Measure
Slope of mesopic retinal sensitivity decline (dB/year) at predefined distances from the Geographic Atrophy (GA) border. [ Time Frame: Duration per participant: 24 months (36-month total project timeline including start-up, ~6-month recruitment, and ~3-month close-out/analysis). ]
Central Contacts
- Jenny Mireles+1
- Ray Nelson+1
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Utah, Department of Ophthalmology, John A. Moran Eye Center | Salt Lake City | Utah | 84132 | - |
Find similar trials in Salt Lake City, UT
Related Studies
- Observational Study to Assess Endpoint Operational Feasibility & Measurement Properties in Patients with Retinal DegenerationRecruiting · Ray Therapeutics, Inc. · Irvine, California
- Development and Evaluation of Functional Visual Field and Navigation Endpoints in Moderate to Profound Inherited Retinal Disease (DEFINE-IRD)Recruiting · Ray Therapeutics, Inc. · Irvine, California